GREETINGS

본문 바로가기

COMPANY
COMPANY GREETINGS
GREETING

PLATFORM TECHNOLOGY

IntoCell was established with a bold vision of commercializing innovative ADC platform technologies based on creative ideas and technical excellence, breaking away from traditional small molecule-based drug discovery and development.

IntoCell’s leadership team has already had management experience of co-founding a venture company that subsequently listed on the KOSDAQ stock exchange. By combining extensive experience of successfully developing ADC technologies with a broad industry network, we are confident that our vision will come to be realized.

GLOBAL BIOTECH

IntoCell has already succeeded in proving the concept behind its original ideas through diligent and practical research and development. It is now focusing on find partners for its technology platform and the in-house development of therapeutic candidates in the anti-cancer area.

Tae-Kyo Park, CEO of IntoCell


사이트 정보

COMPANY : INTOCELL CEO : Tae-Kyo Park ADDRESS : 101, Sinildong-ro, Daedeok-gu, Daejeon, Republic of Korea
TEL : +82 - 042 - 716 - 0083 FAX : +82 - 042 - 716 - 0084

Copyright © INTOCELL All rights reserved.